Inhibitors of Apoptosis Proteins Expression and Their Prognostic Significance in Colorectal Carcinoma
결장직장암종에서 세포자멸사억제단백의 발현과 예후인자로서의 중요성
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The expression of the inhibitor of apoptosis proteins (IAPs) family has not been fully investigated in colorectal carcinomas. This study investigated IAP expression in colorectal carcinomas and assessed their prognostic significance. Methods: Livin, XIAP, and SMAC/DIABLO expression was assessed by immunohistochemistry in 159 colorectal carcinomas. Correlations between protein expression and clinicopathological features were evaluated. The survival data analysis was estimated according to the Kaplan-Meier method. Results: Increased expression of IAPs in cancer tissues compared to surrounding nonneoplastic counterparts was observed in 67 cases (42.1%) for Livin, 50 cases (31.4%) for XIAP, and 68 cases (42.8%) for SMAC. A significant correlation was found between Livin expression and tumor differentiation, and SMAC expression and tumor location. The recurrence-free and overall survival of patients with low Livin expression were inferior to those of patients with high Livin expression (p=0.054 and 0.095, respectively). High XIAP expression was significantly associated with shorter progression-free survival (p= 0.041). Conclusions: Our study demonstrated that altered expression of IAP family members, including Livin, XIAP, and SMAC, is frequent in colorectal carcinoma. This result suggests that high Livin expression and low XIAP expression may be a favorable prognostic implication related to patient survival.
Abstract
a
참고문헌 (29)
- Jemal A, "Cancer statistics, 2010", CA Cancer J Clin, 60, pp.277~300 (2010)
- Huerta S, "Colon cancer and apoptosis", Am J Surg, 191, pp.517~526 (2006)
- LaCasse EC, "IAP-targeted therapies for cancer", Oncogene, 27, pp.6252~6275 (2008)
- Liu B, "Livin", ML-IAP as a new target for cancer treatment, 2007, pp.250, 168~176
- Choi J, "Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia", BLOOD, 109, pp.471~477 (2007), AMER SOC HEMATOLOGY
- Tanabe H, "Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer", Lung Cancer, 46, pp.299~304 (2004)
- Gazzaniga P, "Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer", Ann Oncol, 14, pp.85~90 (2003)
- Kim DK, "Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome", Pediatr Dev Pathol, 8, pp.621~629 (2005)
- Crnković-Mertens I, "The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells", Lung Cancer, 54, pp.135~142 (2006)
- Wang R, "Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells", Cancer Gene Ther, 15, pp.402~412 (2008)
- Edge SB, "AJCC cancer staging manual. 7th ed" (2009), Springer
- Vucic D, "ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas", Curr Biol, 10, pp.1359~1366 (2000)
- Ashhab Y, "Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern", FEBS Lett, 495, pp.56~60 (2001)
- Wang TS, "Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene", Biomed Pharmacother, 64, pp.333~338 (2010)
- Wang X, "Livin gene plays a role in drug resistance of colon cancer cells", Clin Biochem, 43, pp.655~660 (2010)
- Xiang Y, "Prognostic value of Survivin and Livin in nasopharyngeal carcinoma", Laryngoscope, 116, pp.126~130 (2006)
- Augello C, "Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma", BMC Cancer, 9, pp.125~ (2009)
- Gordon GJ, "Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma", J Pathol, 211, pp.447~454 (2007)
- Abd-Elrahman I, "The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity", Cancer Res, 69, pp.5475~5480 (2009)
- Ye L, "Livin-alpha promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer", Prostate, 71, pp.42~51 (2011)
- Nachmias B, "Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin", Apoptosis, 12, pp.1129~1142 (2007)
- Eckelman BP, "Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family", EMBO Rep, 7, pp.988~994 (2006)
- Fulda S, "Inhibitor of apoptosis proteins in hematological malignancies", Leukemia, 23, pp.467~476 (2009)
- Endo T, "Expression of IAP family proteins in colon cancers from patients with different age groups", Cancer Immunol Immunother, 53, pp.770~776 (2004)
- Shi YH, "Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence", Hepatology, 48, pp.497~507 (2008)
- Xiang G, "Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis", J Surg Oncol, 100, pp.708~712 (2009)
- Vucic D, "SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)", J Biol Chem, 277, pp.12275~12279 (2002)
- Vucic D, "Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP", Biochem J, 385(Pt 1), pp.11~20 (2005)
- Endo K, "Clinical significance of Smac", DIABLO expression in colorectal cancer, 2009, pp.21, 351~355